Effect of F2695 on Functional Recovery After Ischemic Stroke "LIFE"


Phase 3 Results N/A

Summary of Purpose

The purpose of the study is to assess the efficacy of a new serotonin-norepinephrine reuptake inhibitor (SNRI) nin functional recovery after ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 March 2015.

1 Jul 2012 10 Jul 2012 1 Feb 2015 1 Feb 2015 1 Mar 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment